Cerebellar growth in normal and growth-restricted fetuses of multiple gestations
Article Abstract:
The growth retarded fetus may preserve the growth of its brain, as noted by normal measurements of brain diameter in small-for-age fetuses. Researchers performed ultrasound examinations on the fetuses of pregnant women and compared brain diameter measurements of normal-for-gestational age fetuses with those of growth-restricted fetuses in twin and triplet pregnancies. The transverse cerebellar diameter measurement was found to be fairly constant among normal and growth-restricted fetuses, and correlated well with gestational age. Other body measurements of growth-restricted fetuses were smaller than normal, with most measurements below the tenth percentile. Early diagnosis of fetal growth retardation may allow intervention that can prevent fetal death.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Do low-risk pregnant women with antiphospholipid antibodies need to be treated?
Article Abstract:
Low-risk pregnant women who have antiphospholipid antibodies may not benefit from treatment with aspirin. Researchers identified 19 pregnant women with antiphospholipid antibody syndrome, a syndrome which can result in significant complications for both mother and fetus, but who did not exhibit symptoms of the syndrome and who had low rates of fetal compromise. Eleven women received treatment with low doses of aspirin while eight women received standard obstetric care. A low rate of fetal compromise was found in both groups, suggesting that aspirin treatment is not warranted for similar low-risk women.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
Dietary intake of myo-inositol and neural tube defects in offspring of diabetic rats
Article Abstract:
Supplementing the diets of diabetic pregnant women with myo-inositol may decrease by half the occurrence of birth defects among their infants. Myo-inositol is a fat that occurs in membranes, the integrity of which may be important in the developing embryo. Researchers studied the effects of induced diabetes and myo-inositol administration on 70 pregnant rats. Embryos of rats that received myo-inositol had half as many neural tube defects as embryos of rats not given myo-inositol, 9.5% versus 20.4%. High levels of maternal blood sugar, as occurs in diabetes, may cause birth defects.
Publication Name: American Journal of Obstetrics and Gynecology
Subject: Health
ISSN: 0002-9378
Year: 1997
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Prescribing for Seniors. Oral drug therapy for multiple neglected tropical disease. Preventing pressure ulcers: A systematic review
- Abstracts: The empiric use of gonadotropin therapy and intrauterine insemination. Micromanipulative and conventional insemination strategies for assisted reproductive technology
- Abstracts: Do miracle hair removers really work? We test and tell. The unexpected beauty side effects of medications. Bruises: how to ease the pain, cover them up and speed them on their way
- Abstracts: Just rewards on the wards. Children first?: as the House of Commons health committee prepares for its investigation into children's health
- Abstracts: MHC-restricted T-cell recognition: the basis of immune surveillance. The keys to cell-mediated immunity